Bristol Myers Squibb - Latest News [Page 1]
New Zealanders Can Now Access Funded OPDIVO® (Nivolumab) For Previously Treated Metastatic Renal Cell Carcinoma
Saturday, 2 November 2024, 6:33 pm | Bristol Myers Squibb
This OPDIVO funding marks the first kidney cancer medicine decision following the New Zealand Government’s funding boost announced June 2024. More >>